[1] Li Tianhao, Ma Jiangang, Gao Xiaojuan, et al. Clinical Evaluation of Wendan Decoction in the Treatment of COPD with Anxiety and Depression [J]. Modern Traditional Chinese Medicine, 2019, (06): 69-72. [doi: 10.13424/j.cnki.mtcm.2019.06.021]
Clinical Evaluation of Wendan Decoction in the Treatment of COPD with Anxiety and Depression
- Article number:
- 1672-0571(2019)06-0069-04
- ZTFLH:
- R749.7+2
- Code:
- A
- Abstract:
- To observe the clinical efficacy of Wendan Decoction in the treatment of COPD with anxiety and depression. Methods: 42 patients with stable COPD were randomly divided into control group and treatment group, 22 cases in control group and 20 cases in treatment group. Both groups were given budesonide formoterol ( 320ug/9ug) inhalation twice a day and anti - anxiety and depression treatment. The treatment group was treated with Wendan Decoction on the basis of the above treatment for 4 weeks as a course of treatment. The changes of 6MWD, FEV1, FEV1/ FVC,HAMD score and HAMA score before and after treatment were compared between the two groups. Results: After treatment, 6MWD, FEV1, FEV1/ FVC were improved in both groups ( P < 0. 05) , HAMA score and HAMD score were decreased ( P < 0. 05) , and the improvement of 6MWD, FEV1, FEV1/ FVC in treatment group was better than that in control group ( P < 0. 05) , HAMA score and HAMD score were better than those in control group ( P < 0. 05) . Compared with the control group, it was significantly lower ( P < 0. 05) . Conclusion: Wendan Decoction is effective in treating COPD with anxiety and depression.
References:
[1]杨小骏,陈文晖,杨方,等.慢性阻塞性肺疾病患者血清PCT,IL-6及CRP与BODE指数的相关性研究[J].临床肺科杂志,2016,21(11):2028-2031.
[2]苏永超,田作春,李才,等.低糖高脂肠内营养在慢性阻塞性肺疾病急性发作并发呼吸衰竭患者治疗中的应用[J].重庆医学,2018,47(1):103-105.
[3] Safa M, Fallah Tafti S, Talischi F, et al. Severity of anxiety disorders in patients with chronic obstructive pulmonary disease[ J] . Iran J Psychiatry, 2015, 10( 2) : 128 -132.
[4] Pascal OI, Trofor AC, Lotrean LM, et al. Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: correlations with tobacco use, disease severity and quality of life[ J] . Tob Induc Dis, 2017,15:23.
[5]许银芳,韩淑华,林勇.慢性阻塞性肺疾病患者合并焦虑/抑郁障碍[J].中国老年学杂志,2012,32(15):3180-3182.
[6] GOLD 2018 Global Strategy for the Diagnosis, Management and Prevention of COPD[ EB/ OL] . ( 2017 - 11 -15) [ 2017 - 12 - 22] http: / / goldcopd. org/ wp - content/uploads/2017/11/ GOLD -2018 - v6. 0 - FINAL - revised-20 - Nov - WMS. pdf.
[7]朱昌明,张明圆.抑郁量表/焦虑量表,精神科评定量表手册[M].2版.长沙:湖南科学技术出版社,1998:121-140.
[8]许建中.慢性阻塞性肺疾病中医诊治探讨[J].江苏中医药,2006,27(7):4-5.
[9]王延科,张维录.张维录教授中西医结合治疗慢性阻塞性肺疾病经验[J].陕西中医药大学学报,2016,39(2):17-20.
[10]李博,张庆萍,杨骏.杨骏教授针刺治疗慢性病的调神观[J].陕西中医药大学学报,2018,41(5):146-148